Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Shares Issued (2024)

Caris Life Sciences has reported Shares Issued over the past 1 years, most recently at -$603000.0 for Q3 2024.

  • Quarterly results put Shares Issued at -$603000.0 for Q3 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was -$603000.0 (changed N/A YoY), and the annual figure for FY2025 was $528.5 million, changed.
  • Shares Issued for Q3 2024 was -$603000.0 at Caris Life Sciences.
  • Over the last five years, Shares Issued for CAI hit a ceiling of -$603000.0 in Q3 2024 and a floor of -$603000.0 in Q3 2024.